The neutrophil-to-lymphocyte ratio as a new prognostic factor in cancers: a narrative review
Frontiers in Oncology · 04.10.2023 · 13
DOI: 10.3389/fonc.2023.1228076 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 04.10.2023. Verfasst von Kian Heshmat-Ghahdarijani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cardiac Rehabilitation, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The increasing incidence of cancer globally has highlighted the significance of early diagnosis and improvement of treatment strategies. In the 19th century, a connection was made between inflammation and cancer, with inflammation recognized as a malignancy hallmark. The neutrophil-to-lymphocyte ratio (NLR), calculated from a complete blood count, is a simple and accessible biomarker of inflammation status. NLR has also been proven to be a prognostic factor for various medical conditions, including mortality classification in cardiac patients, infectious diseases, postoperative complications, and inflammatory states. In this narrative review, we aim to assess the prognostic potential of NLR in cancer. We will review recent studies that have evaluated the association between NLR and various malignancies. The results of this review will help to further understand the role of NLR in cancer prognosis and inform future research directions. With the increasing incidence of cancer, it is important to identify reliable and accessible prognostic markers to improve patient outcomes. The study of NLR in cancer may provide valuable insights into the development and progression of cancer and inform clinical decision-making.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiac Rehabilitation, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
- School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
- School of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
- Department of Biostatistics and Epidemiology, University of California, San Francisco, San Francisco, CA, United States.
Zitieren
APA
Heshmat-Ghahdarijani, K., Sarmadi, V., Heidari, A., Falahati Marvasti, A., Neshat, S., & Raeisi, S. (2023). The neutrophil-to-lymphocyte ratio as a new prognostic factor in cancers: a narrative review. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1228076
Vancouver
Heshmat-Ghahdarijani K, Sarmadi V, Heidari A, Falahati Marvasti A, Neshat S, Raeisi S. The neutrophil-to-lymphocyte ratio as a new prognostic factor in cancers: a narrative review. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1228076
BibTeX
@article{HeshmatGhahdarijani2023,
author = {Heshmat-Ghahdarijani, Kian and Sarmadi, Vida and Heidari, Afshin and Falahati Marvasti, Alireza and Neshat, Sina and Raeisi, Sina},
title = {The neutrophil-to-lymphocyte ratio as a new prognostic factor in cancers: a narrative review},
journal = {Frontiers in Oncology},
year = {2023},
volume = {13},
doi = {10.3389/fonc.2023.1228076}
}
EUVIMED